About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPD Clinical Trials in Houston | 164 Studies

Clinical Trials COPDHouston

COPD Clinical Trials in Houston

Find 164 clinical trials for copd near Houston, Texas. Connect with research centers in your area.

All COPD trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 141-160 of 164 trials

CompletedINtervention Study In overweiGHT Patients With COPDSymptoms of chronic obstructive pulmonary disease (COPD) and high body mass index (BMI) overlap.NCT02634268·Birmingham, Alabama and 38 others

PreviousPage 8 of 9Next

COPD Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedDose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD)The purpose of this study is to evaluate the efficacy and safety of GSK233705B compared with placebo in subjects with COPD.NCT00676052·Jasper, Alabama and 87 others

Active not recruitingA Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPDThis is an open-label Phase II study assessing the PD of dexpramipexole 150 mg twice daily (BID) in participants with eosinophilic COPD.NCT06533553·Conway, Arkansas and 22 others

CompletedCharacterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary DiseaseThe study is intended to characterize the lung function profile of BI1744 in COPD patients where patients will perform pulmonary function tests at regular intervals for 24 hours…NCT00932646·Jasper, Alabama and 12 others

CompletedIntermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic BronchitisMoxifloxacin, is being tested at approximately 60 study centres in 15 countries to determine if this drug, when taken periodically in addition to the patients normal treatment, is…NCT00473460·Tucson, Arizona and 77 others

CompletedAn Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHFThe primary objective of this observational study is to determine the incidence of medically attended (inpatient or outpatient) acute respiratory illnesses or events leading to…NCT01455402·Birmingham, Alabama and 59 others

CompletedA Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPDThe purpose of this study is to compare CHF 5993 with CHF 1535 in improving lung function, reducing moderate and severe COPD exacerbations, and other clinical efficacy and safety…NCT04320342·Birmingham, Alabama and 435 others

CompletedComparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic FibrosisCystic fibrosis (CF) is a chronic disease that significantly affects an individual's lung function.NCT00097773·Birmingham, Alabama and 53 others

CompletedSafety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) SubjectsThis is a multi-center study to evaluate the long-term safety of arformoterol 15 mcg twice daily (BID) in the treatment of subjects with moderate-to-severe COPD.NCT00909779·Birmingham, Alabama and 72 others

CompletedStudy to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos)This is a randomized, double-blind, multi-center, parallel-group study to assess the efficacy and safety of PT010 relative to PT003 and PT009 on COPD exacerbations subjects with…NCT02465567·Andalusia, Alabama and 740 others

CompletedA 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).The purpose of the study is to determine the efficacy and safety of the combination of ADVAIR DISKUS® 250/50mcg (FLUTICASONE PROPIONATE/SALMETEROL COMBINATION PRODUCT) plus…NCT00784550·Riverside, California and 34 others

CompletedA Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseThis study will evaluate the efficacy, safety, and pharmacokinetics of astegolimab in combination with standard of care chronic obstructive pulmonary disease (COPD) maintenance…NCT05037929·Dothan, Alabama and 192 others

CompletedAdvair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease ExacerbationsThis study evaluates the effect of two medicines on COPD (Chronic Obstructive Pulmonary Disease) exacerbations.NCT00115492·Jasper, Alabama and 109 others

TerminatedA Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD)This is a pilot study to investigate the effect of danirixin hydrobromide 35 milligram (mg) tablets on lung function and health related quality of life (HRQoL) in subjects with…NCT03170232·Birmingham, Alabama and 10 others

RecruitingEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic PhenotypeThis is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in…NCT07190222·Birmingham, Alabama and 314 others

CompletedTo Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPDThe purpose of this study is to determine the long-term safety of arformoterol over a period of 12 months in subjects with COPDNCT00064415·Anniston, Alabama and 89 others

RecruitingClinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPDThis research is being done to test if a drug called omalizumab can help people with Chronic Obstructive Pulmonary Disease (COPD) and allergies.NCT07059091·Birmingham, Alabama and 22 others

TerminatedA Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPDThe purpose of this study is to determine whether ODSH, when added to conventional treatment, is more effective in treating COPD exacerbations than conventional therapy alone.NCT00457951·Orange, California and 37 others

CompletedADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.This study evaluates the effect of two medicines on COPD (Chronic Obstructive Pulmonary Disease) exacerbations.NCT00144911·Birmingham, Alabama and 96 others

Active not recruitingExamining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that is often caused by cigarette smoking.NCT00608764·Birmingham, Alabama and 19 others

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia